Literature DB >> 16508775

Proteinuria and renal disease: prognostic value of urine dipstick testing for leukocytes.

Shira Koss1, Ari Perl, Adinah Wieder, Rachel Frank, Suzanne Vento, Howard Trachtman.   

Abstract

Proteinuria is utilized to screen for underlying kidney disease and serves as a marker of disease progression. The aim of this study was to test the hypothesis that patients with proteinuria will have a higher frequency of urine dipstick positive for leukocytes as an index of noninfectious renal inflammation. In this retrospective analysis, 1,099 urine specimens were evaluated from 676 patients. Proteinuria was present in 39% of the samples and leukocyturia in 5.1%. The percentage of urines that were dipstick positive for leukocytes was similar in those specimens with or without proteinuria. However, in patients with proteinuria and concomitant leukocyturia, the mean serum creatinine concentration was higher (P=0.003) and the calculated GFR was lower (P=0.01) compared to those without this additional abnormality. These differences were noted despite similar age, gender distribution, and array of underlying diseases in these two groups. Based on these findings, urine dipstick testing for leukocytes as a primary means of screening otherwise healthy children for serious renal disease is of little value. However, in patients with established proteinuria, a positive dipstick result for leukocytes is a simple means of identifying those with more prominent noninfectious renal inflammation, a process which may promote kidney disease progression. This finding may serve as an early marker of the severity of renal injury, regardless of whether the primary process is glomerular or tubular.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508775     DOI: 10.1007/s00467-006-0015-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

Review 1.  Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).

Authors:  Garabed Eknoyan; Thomas Hostetter; George L Bakris; Lee Hebert; Andrew S Levey; Hans-Henrik Parving; Michael W Steffes; Robert Toto
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

Review 2.  The future of renoprotection.

Authors:  Norberto Perico; Igor Codreanu; Arrigo Schieppati; Giuseppe Remuzzi
Journal:  Kidney Int Suppl       Date:  2005-08       Impact factor: 10.545

3.  Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.

Authors:  Stephanie Krämer; Tanja Loof; Sebastian Martini; Matthias Rückert; Yingrui Wang; Torsten Böhler; Fuijo Shimizu; Hiroshi Kawachi; Hans-H Neumayer; Harm Peters
Journal:  Am J Physiol Renal Physiol       Date:  2005-03-15

4.  Serial evaluation of cell surface markers for immune activation after acute renal allograft rejection by urine flow cytometry--correlation with clinical outcome.

Authors:  I Roberti; L Reisman
Journal:  Transplantation       Date:  2001-05-15       Impact factor: 4.939

5.  Hematuria and proteinuria in a mass school urine screening test.

Authors:  Yong-Hoon Park; Jung-Youn Choi; Hyo-Seok Chung; Ja-Wook Koo; Su-Yung Kim; Mee-Kyung Namgoong; Young-Seo Park; Kee-Hwan Yoo; Kyung-Yil Lee; Dae-Yeol Lee; Seung-Joo Lee; Ji-Eun Lee; Woo-Yeong Chung; Tae-Sun Hah; Hae-Il Cheong; Yong Choi; Kyung-Soo Lee
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

6.  Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts.

Authors:  Mauro Abbate; Carla Zoja; Daniela Rottoli; Daniela Corna; Susanna Tomasoni; Giuseppe Remuzzi
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

7.  Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat.

Authors:  Bernardo Rodríguez-Iturbe; Yasmir Quiroz; Ashkan Shahkarami; Zhen Li; Nosratola D Vaziri
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

Review 8.  Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective.

Authors:  James T Lane
Journal:  Am J Physiol Renal Physiol       Date:  2004-03

9.  Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.

Authors:  Piero Ruggenenti; Annalisa Perna; Giuseppe Remuzzi
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

10.  Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.

Authors:  Ruth Campbell; Fabio Sangalli; Elena Perticucci; Claudio Aros; Cecilia Viscarra; Annalisa Perna; Andrea Remuzzi; Federico Bertocchi; Luca Fagiani; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.